Starlight Cardiovascular’s Kathryn Olson gives thoughtful insights on generating impactful clinical evidence as a resource-limited start-up at the Impact1 at Stanford Biodesign Pediatric MedTech CEO summit hosted at the beautiful Cure building by Emma Moran and CobiCure
关于我们
Starlight Cardiovascular is developing much needed tools and devices to treat pediatric Congenital Heart Defects (CHDs). Approximately 1.3 million babies are born each year with a CHD. Most of the tools used to treat these children were designed for adult conditions and anatomy, limiting their utility for pediatric patients. Starlight Cardiovascular is developing a portfolio of devices designed and tested specifically for pediatric CHD with the goals of improving morbidity, mortality, and access to care.
- 网站
-
https://www.starlightcardio.com
Starlight Cardiovascular的外部链接
- 所属行业
- 医疗设备
- 规模
- 2-10 人
- 总部
- San Diego，California
- 类型
- 私人持股
地点
-
主要
获取路线
9710 Scranton Rd
Suite 100
US，California，San Diego，92121
Starlight Cardiovascular员工
动态
-
...and that's a wrap! It's been another successful summer internship season at Starlight. Thanks to Priya Nair [Stanford], Nicole Schnettler [Cal Poly SLO], Jessica Finch [Cal Poly SLO], and Fikunwa Kolawole [Stanford] for all your hard work this summer! [middle row, left to right] We wish you all the best in your future endeavors, and we know that you are going to accomplish amazing things in #MedTech!
-
-
Starlighters Anna and Kathryn soaking up "The Power of We" at #MedtechVision2024! Poignant patient keynote by Brooke Story, timely panels about private / public / strategic partnerships, much-deserved Ferolyn Powell Leadership Award winner Deborah K., and the ever-important message of reaching down to pull others up to create the medical ecosystem we all want to see. #BeTheChange MedtechWOMEN
-
-
Welcome?Anna Burke?to the?Starlight Cardiovascular?team! We are thrilled to be bringing one of our exceptional interns from?California Polytechnic State University-San Luis Obispo?on as a R&D Engineer. Anna was awarded early career funding from?The National Institutes of Health, and Starlight is proud to mentor her through the grant.
-
-
Starlight Cardiovascular has been awarded a $2M Phase II SBIR grant from the?National Heart, Lung, and Blood Institute to support development of Pulmonary Flow Restrictors. "Not only will this new device help improve the outcomes for babies with Hypoplastic Left Heart Syndrome undergoing a hybrid procedure, but these innovative Pulmonary Flow Restrictors will open up a myriad of other applications to the benefit of children with Congenital Heart Disease." - Dr. Mark Galantowicz,?Chief of Cardiothoracic Surgery and Director of The Heart Center at Nationwide Children's Hospital. #medtech #pediatrics #chd #NHLBI #SBIR Learn more at https://lnkd.in/gmDXt68H